SKYE
Skye Bioscience, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.53
−1.29%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$1.14
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.27
- EPS estimate
- -$0.25
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -16.7%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.25 | -$0.27 | Miss -5.89% | — |
| May 12, 2026 | -$0.29 | -$0.32 | Miss -10.34% | — |
| Mar 10, 2026 | -$0.30 | -$0.36 | Miss -21.17% | — |
| Aug 7, 2025 | -$0.34 | -$0.44 | Miss -29.41% | — |
| May 8, 2025 | -$0.31 | -$0.28 | Beat 9.68% | — |
| Mar 20, 2025 | -$0.28 | -$0.24 | Beat 14.29% | — |
| Nov 7, 2024 | -$0.26 | -$0.22 | Beat 15.38% | — |
| Aug 9, 2024 | -$0.20 | -$0.20 | In line | — |
| May 10, 2024 | -$0.16 | -$0.18 | Miss -12.50% | — |
| Mar 22, 2024 | -$0.38 | -$0.63 | Miss -65.79% | $163.4K |
| Nov 13, 2023 | — | -$3.17 | — | — |
| May 11, 2023 | — | -$2.50 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026